<?xml version="1.0" encoding="UTF-8"?>
<p id="p0225">Furthermore, if prominent mitochondrial dysfunction occurs in COVID-19, evaluation of its use as a biomarker for infection susceptibility and severity of disease progression will be of interest, thanks to accessible mitochondria-related biomarkers (e.g., in the blood), such as oxidative stress markers, respirational capacities of blood cells, or circulating mitochondrial DNA.</p>
